Neutralizing antibody levels against Sars-CoV-2 Variants of concern delta and omicron in vaccine Breakthrough-Infected blood donors
Description
BACKGROUND: Novel SARS-CoV-2 variants of concern (VOC) Delta and Omicron are able to escape some monoclonal antibody therapies, making again COVID-19 convalescent plasma (CCP) a potential frontline treatment.
